Hazardous Materials Information Review Commission
www.hmirc-ccrmd.gc.ca
Common menu bar links
Decisions and Orders
HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION
July 5, 2008
HAZARDOUS MATERIALS INFORMATION REVIEW ACT
Decisions and orders on claims for exemption
Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.
|
Claimant |
Product Identifier |
Registry Number |
MSDS |
Date of Decision |
|
Milacron Marketing Co., Cincinnati, Ohio |
CIMPERIAL® 1080CFZ |
6082 |
8/31/2006 |
May 9, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE LIQUID (SERIES 100) formerly |
6183 |
8-1-2007 |
February 8, 2008 |
|
Cytec Industries Inc., |
CYCOM® 5208GD Structural Prepreg |
6221 |
07/08/2005 |
May 1, 2008 |
|
Cytec Industries Inc., |
FM® 94 Adhesive Film |
6222 |
07/08/2005 |
May 1, 2008 |
|
Cytec Industries Inc., |
FM® 300-1 Adhesive Film |
6223 |
02/16/2007 |
May 1, 2008 |
|
Cytec Industries Inc., |
CYCOM® 985 Prepreg |
6224 |
07/08/2005 |
January 25, 2008 |
|
Cytec Industries Inc., |
HYE E773FR/Glass Prepreg |
6225 |
07/08/2005 |
January 25, 2008 |
|
Cytec Industries Inc., |
MXB 9032/Glass Prepreg |
6226 |
07/08/2005 |
January 25, 2008 |
|
Cytec Industries Inc., |
FX 986/Carbon Filament Prepreg |
6227 |
07/08/2005 |
January 25, 2008 |
|
Cytec Industries Inc., |
SURFACE MASTER® 905 |
6228 |
07/08/2005 |
January 25, 2008 |
|
Cytec Industries Inc., |
CYCOM® 114/Glass Prepreg |
6230 |
07/08/2005 |
January 25, 2008 |
|
Nexco Inc., |
NSOL 1000 |
6231 |
June 24, 2005 |
February 12, 2008 |
|
3M Canada Company, London, Ontario |
3M(TM) PIEZO INK JET INK 1595 BLACK |
6235 |
2007/04/09 |
February 8, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE POWDER (SERIES 100) |
6238 |
8-1-2007 |
January 29, 2008 |
|
Hercules Canada Inc., Mississauga, Ontario |
PROSOFT® TQ1003 SOFTENER formerly |
6246 |
15-AUG-2005 |
February 12, 2008 |
|
Hach Company, Ames, Iowa |
DPD Free Chlorine Reagent |
6249 |
10/16/07 |
January 31, 2008 |
|
Hach Company, Ames, Iowa |
DPD Total Chlorine Reagent |
6250 |
10/16/07 |
January 31, 2008 |
|
Hach Company, Ames, Iowa |
DPD Compound for Free and Total Chlorine Analyzers |
6251 |
10/16/07 |
January 31, 2008 |
|
Lubrizol Corporation, formerly |
LUBRIZOL® 5706 |
6261 |
11 December 2007 |
April 18, 2008 |
|
Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario |
Fentak™ MR0950 formerly |
6274 |
08-DEC-2006 |
January 30, 2008 |
|
Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario |
Fentak™ UR0269 |
6277 |
08-DEC-2006 |
January 30, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
LUBRIZOL® 9690 |
6283 |
05 April 2007 |
April 18, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
C-5777 |
6287 |
9/7/2006 |
January 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® 300-T |
6290 |
5/17/2007 |
March 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® 500-T |
6292 |
5/17/2007 |
March 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® AD-11-1A |
6293 |
1/20/2006 |
January 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® 727 |
6294 |
5/17/2007 |
March 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® N-141B |
6295 |
1/20/2006 |
March 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® N-500B |
6296 |
1/20/2006 |
February 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® B723 |
6297 |
1/20/2006 |
February 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® AM-1-23 C |
6298 |
1/20/2006 |
February 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® AM-1-23 D |
6299 |
1/20/2006 |
February 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
SPONTO® EC-300 |
6300 |
1/20/2006 |
February 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
ARMOHIB® PC-105 |
6302 |
8/16/2007 |
January 31, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
WITBREAK® 770 |
6303 |
5/17/2007 |
March 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
WITBREAK® DRM-9510 |
6304 |
1/20/2006 |
March 27, 2008 |
|
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois |
WITCOMUL™ 3158 |
6305 |
11/08/2005 |
February 27, 2008 |
|
Arkema Canada Inc., |
THERMOLITE® 176 |
6317 |
11/25/05 |
April 28, 2008 |
|
Arkema Canada Inc., |
PA-1121 |
6318 |
11/29/05 |
April 28, 2008 |
|
BYK USA Inc., formerly |
BYK-9077 |
6410 |
12/14/2005 |
March 31, 2008 |
|
Shell Canada Limited, |
FORMAD05A |
6411 |
2005-12-20 |
March 13, 2008 |
|
Cansolv Technologies Inc., |
CANSOLV® DC 101 Solvent/ |
6412 |
2007-7-3 |
January 15, 2008 |
|
BYK USA Inc., formerly |
BYK-W 969 formerly |
6418 |
12/07/2006 |
April 10, 2008 |
|
3M Canada Company, London, Ontario |
SCOTCH-WELD (TM) EPOXY ADHESIVE DP-190, TRANSLUCENT (PART A) |
6425 |
2007/06/18 |
March 20, 2008 |
|
Enthone, Inc., West Haven, Connecticut |
ENPREP® 126 |
6437 |
8/10/2007 |
January 18, 2008 |
|
Enthone, Inc., West Haven, Connecticut |
ENPREP® 142 |
6438 |
4/26/2007 |
February 6, 2008 |
|
Nalco Canada Co., |
EC9008G |
6468 |
2006/02/03 |
February 21, 2008 |
|
Cytec Industries Inc., |
CYCOM® 919HF Structural Resin |
6469 |
02/03/2006 |
March 27, 2008 |
|
Cytec Industries Inc., |
FM® 87-1 HT Adhesive Film |
6470 |
11/09/2007 |
March 27, 2008 |
|
Cytec Industries Inc., |
CYCOM® 919LB Structural Prepreg |
6471 |
02/03/2006 |
March 27, 2008 |
|
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta |
Bwet |
6476 |
July 17, 2006 |
February 19, 2008 |
|
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta |
DO 110 |
6477 |
August 14, 2006 |
March 14, 2008 |
|
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta |
DO 136 |
6478 |
August 14, 2006 |
March 14, 2008 |
|
Schlumberger Canada Limited, Calgary, Alberta |
Non-Emulsifying Agent W54 formerly |
6487 |
22 October 2007 |
April 22, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCOTCH-WELD (TM) STRUCTURAL PLASTIC ADHESIVE 8100, (PART B) formerly |
6488 |
2007/11/02 |
March 20, 2008 |
|
BYK USA Inc., formerly |
BYK-S-740 |
6491 |
02/23/2006 |
January 31, 2008 |
|
BYK USA Inc., formerly |
BYK-085 |
6492 |
02/23/2006 |
January 31, 2008 |
|
BYK USA Inc., formerly |
BYK-3105 |
6493 |
02/23/2006 |
January 31, 2008 |
|
BYK USA Inc., formerly |
Anti-Terra-207 |
6495 |
04/20/2007 |
April 3, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9800 PROCESS BASE |
6497 |
2007-06-27 |
April 22, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9802 OPAQUE BLACK formerly |
6498 |
2007-06-26 |
April 22, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9803 MIXING BLACK formerly |
6499 |
2007-06-26 |
April 22, 2008 |
|
3M Canada Company, London, Ontario |
9805P Process Black formerly |
6500 |
2007-07-12 |
March 13, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9806 MIXING WHITE |
6501 |
2007-06-25 |
March 3, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9808 OPAQUE WHITE |
6502 |
2007-06-25 |
March 3, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9810 UV TONER |
6503 |
2007/06/25 |
March 31, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9812 MAGENTA |
6504 |
2007/06/25 |
March 31, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK 9813 RED VIOLET |
6505 |
2007/06/25 |
March 31, 2008 |
|
3M Canada Company, London, Ontario |
9815 Process Magenta formerly |
6506 |
2007-07-12 |
March 13, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9825 TRANSPARENT RED (BS) |
6507 |
2007-06-26 |
March 13, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9826 BRICK RED |
6508 |
2007-06-26 |
March 13, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9827 RED |
6509 |
2007/06/26 |
March 31, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9828 TRANSPARENT RED (YS) |
6510 |
2007/06/26 |
March 31, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9830 ORANGE |
6511 |
2007-06-26 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9831 TRANSPARENT ORANGE |
6512 |
2007-06-26 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9837 RED SHADE YELLOW |
6513 |
2007-06-26 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9840 TRANSPARENT MEDIUM YELLOW |
6514 |
2007-06-26 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9843 MEDIUM YELLOW |
6515 |
2007-06-26 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
9845 PROCESS YELLOW formerly |
6516 |
2007-07-12 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9848 TRANSPARENT YELLOW |
6517 |
2007-06-27 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9849 LEMON YELLOW |
6518 |
2007-07-04 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9861 LIGHT GREEN |
6519 |
2007-06-27 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9864 TRANSPARENT GREEN(BS) |
6520 |
2007-06-27 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
9875 PROCESS CYAN formerly |
6521 |
2007-07-13 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9879 BLUE (GS) |
6522 |
2007-06-27 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9882 TRANSPARENT BLUE |
6523 |
2007-06-27 |
March 28, 2008 |
|
3M Canada Company, London, Ontario |
3M (TM) SCREEN PRINTING UV INK SERIES 9891 BLUE VIOLET |
6524 |
2007-06-27 |
March 28, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
CAN-1000 |
6534 |
1/9/2008 |
March 19, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
CAN-1100 |
6538 |
1/10/2008 |
March 19, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
Res-Clean S |
6539 |
1/10/2008 |
February 22, 2008 |
|
Canyon Technical Services, Calgary, Alberta |
Res-Clean PA |
6540 |
1/10/2008 |
February 28, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
LUBRIZOL® 5708 |
6542 |
26 November 2006 |
March 28, 2008 |
|
Cytec Industries Inc., |
CYCOM® 934 Carbon Prepreg |
6547 |
03/27/2006 |
March 25, 2008 |
|
Hexion Specialty Chemicals Inc., Houston, Texas |
EPI-REZ™ 5522-WY-55 |
6552 |
06/03/2007 |
May 30, 2008 |
|
Trican Well Services Ltd., Calgary, Alberta |
FC-3 |
6554 |
November 28, 2005 |
April 30, 2008 |
|
Rohm and Haas Canada LP, |
Monomer QM-1458 |
6566 |
04/27/2006 |
January 14, 2008 |
|
Rohm and Haas Canada LP, |
Monomer QM-1482 |
6567 |
04/27/2006 |
January 14, 2008 |
|
Rohm and Haas Canada LP, |
Monomer QM-516 Experimental formerly |
6568 |
04/27/2006 |
January 31, 2008 |
|
Rohm and Haas Canada LP, |
Monomer QM-833M |
6569 |
04/27/2006 |
January 14, 2008 |
|
Rohm and Haas Canada LP, |
Monomer QM-1326AP |
6570 |
04/27/2006 |
February 13, 2008 |
|
Rohm and Haas Canada LP, |
ADVASTAB™ TM-697 Heat Stabilizer |
6582 |
08/04/2006 |
April 17, 2008 |
|
Rohm and Haas Canada LP, |
ADVASTAB™ TM-697OM Heat Stabilizer |
6583 |
08/04/2006 |
April 17, 2008 |
|
Rohm and Haas Canada LP, |
MORLIFE™ 3300 ASPHALT ADDITIVE |
6585 |
04/27/2006 |
April 29, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID™ KM-352 Powder |
6586 |
04/27/2006 |
April 17, 2008 |
|
Rohm and Haas Canada LP, |
PARALOID™ KM-346 Impact Modifier |
6594 |
04/27/2006 |
April 17, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
LUBRIZOL® 5034A |
6608 |
01 November 2007 |
May 5, 2008 |
|
E.I. duPont Canada Company, Mississauga, Ontario |
ZONYL® 8740 |
6611 |
1-May-2006 |
February 27, 2008 |
|
Photographic Solutions, Inc., Buzzards Bay, Massachusetts |
PEC-12® |
6627 |
15 May, 2006 |
January 30, 2008 |
|
Cytec Industries Inc., |
CYCOM® 1003 Prepreg |
6640 |
06/08/2006 |
March 28, 2008 |
|
Cytec Industries Inc., |
MXB 997/Glass Prepreg |
6641 |
06/08/2006 |
March 28, 2008 |
|
Cytec Industries Inc., |
FM® 94 Prepreg |
6642 |
06/08/2006 |
March 25, 2008 |
|
Cytec Industries Inc., |
BR® 626 Potting Compound |
6643 |
04/07/2006 |
March 28, 2008 |
|
Cytec Industries Inc., |
CYCOM® 890-1 Prepreg |
6644 |
06/08/2006 |
March 28, 2008 |
|
Cytec Industries Inc., |
CYCOM® 890 RTM Resin |
6645 |
06/08/2006 |
March 28, 2008 |
|
Innovative Chemical Technologies Canada Ltd., |
Smart Frac |
6654 |
March 13, 2007 |
May 9, 2008 |
|
E.I. duPont Canada Company, |
“ZONYL” 9933 |
6667 |
18-JAN-2008 |
May 22, 2008 |
|
Acheson Colloids Company, |
Emralon 330 |
6676 |
5/02/2006 (English) 06/05/02 (French) |
February 29, 2008 |
|
Acheson Colloids Company, |
GP 1904 |
6678 |
5/02/2006 (English) 2006.05.02 (French) |
March 27, 2008 |
|
Acheson Colloids Company, |
Emralon 329 |
6680 |
2/09/2006 (English) 06/02/09 (French) |
January 18, 2008 |
|
Acheson Colloids Company, |
TA-026B |
6682 |
6/09/2006 (English) 2007/02/05 (French) |
May 21, 2008 |
|
Acheson Colloids Company, |
LUMIDAG EL-043A |
6683 |
10/18/2007 (English) 06/04/03 (French) |
May 16, 2008 |
|
Acheson Colloids Company, |
DELTAFORGE 1001 |
6685 |
10/09/2007 (English) 07/02/05 (French) |
May 21, 2008 |
|
Acheson Colloids Company, |
DELTAFORGE 1105 |
6686 |
10/25/2007 (English) 07/02/05 (French) |
May 21, 2008 |
|
Hexion Specialty Chemicals Inc., |
EPIKURE™ 3380 Curing Agent |
6689 |
06/03/2007 |
May 30, 2008 |
|
Hexion Specialty Chemicals Inc., |
EPI-REZ™ 3520-WY-55 Resin |
6699 |
06/03/2007 |
May 30, 2008 |
|
Lubrizol Corporation, |
ADDCO® 370P |
6700 |
04 August 2006 |
March 28, 2008 |
|
Innospec Fuel Specialties, LLC |
DDA-3565-ff1 |
6711 |
07 September 2006 |
February 27, 2008 |
|
Henkel Canada Corporation, Mississauga, Ontario formerly |
DTI M3-A CUPPER formerlyDTI M3-A Cupper |
6712 |
Jan07/08 |
May 12, 2008 |
|
Henkel Canada Corporation, Mississauga, Ontario formerly |
DTI C1-A CUPPER formerlyDTI C1-A Cupper |
6713 |
Jan07/08 |
May 12, 2008 |
|
Henkel Canada Corporation, Mississauga, Ontario formerly |
DTI 8100-A POST LUBE formerly |
6714 |
Jan07/08 |
May 12, 2008 |
|
Hexion Specialty Chemicals Inc., Houston, Texas |
EPIKUREÔ 9551 Curing Agent |
6719 |
06/03/2007 |
May 30, 2008 |
|
Raybo Chemical Company, Huntington, West Virginia |
RAYBO 57 OPTISPERSE HS |
6724 |
Oct31/07 (English) OCT31/07 (French) |
January 18, 2008 |
|
Raybo Chemical Company, Huntington, West Virginia |
RAYBO 85 RUSTIB |
6725 |
Oct31/07 (English) OCT31/07 (French) |
January 18, 2008 |
|
Raybo Chemical Company, Huntington, West Virginia |
RAYBO 60 NORUST |
6726 |
Oct31/07 (English) OCT31/07 (French) |
March 6, 2008 |
|
Taylor Technologies, Inc., Sparks, Maryland |
DPD REAGENT #2/REACTIF DPD #2 |
6727 |
2006/10/12 |
April 8, 2008 |
|
Innospec Fuel Specialties, LLC Newark, Delaware |
OLI-9101.x |
6732 |
17 October 2006 |
February 11, 2008 |
|
Innospec Fuel Specialties, LLC Newark, Delaware |
Stadis ® 450 |
6733 |
13 October 2006 |
February 11, 2008 |
|
Innospec Fuel Specialties, LLC Newark, Delaware |
Stadis ® 425 |
6734 |
06 October 2006 |
February 11, 2008 |
|
Innospec Fuel Specialties, LLC Newark, Delaware |
DCI 4A formerly |
6744 |
26 October 2006 |
February 11, 2008 |
|
Innospec Fuel Specialties, LLC Newark, Delaware |
DCI 6A formerly |
6745 |
26 October 2006 |
February 11, 2008 |
|
Dow Chemical Canada Inc., Calgary, Alberta |
UCON(TM) COMPRESSOR LUBRICANT RSC-155/LUBRIFIANT UCON(MC) RSC-155 POUR COMPRESSEURS |
6766 |
2006.11.15 |
April 24, 2008 |
|
Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario |
Fentak™ FW0926 |
6816 |
12-DEC-2006 |
May 14, 2008 |
|
Acheson Colloids Company, |
LUMIDAG EL-047 |
6819 |
10/19/2007 (English) 06/10/10 (French) |
March 18, 2008 |
|
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta |
AXE 707C |
6822 |
December 20, 2006 |
March 31, 2008 |
|
BYK USA Inc., formerly |
BYK-9076 |
6881 |
11/06/2007 |
March 31, 2008 |
|
BYK USA Inc., formerly |
Disperbyk-130 |
6882 |
11/06/2007 |
April 30, 2008 |
|
Oxylene Limited, Vancouver, British Columbia |
OXYLENE™ Additive |
6901 |
2007 02 15 |
February 22, 2008 |
|
Cytec Industries Inc., |
CYCOM® 7701 Structural Prepreg |
6908 |
03/15/2007 |
February 4, 2008 |
|
Cytec Industries Inc., |
CYCOM® 3200 Structural Prepreg |
6912 |
03/15/2007 |
February 4, 2008 |
|
Cytec Industries Inc., |
CYCOM® 3288 Structural Prepreg |
6914 |
03/15/2007 |
February 4, 2008 |
|
Lubrizol Corporation, Wickliffe, Ohio |
LUBRIZOL® 5706A |
6923 |
11 December 2007 |
April 16, 2008 |
|
Innospec Fuel Specialties, LLC Newark, Delaware formerly |
DCI-11 |
6949 |
12 April 2007 |
March 26, 2008 |
|
BYK USA Inc., Wallingford, Connecticut |
ANTI-TERRA-U 80 |
7031 |
06/01/2007 |
April 30, 2008 |
|
BYK USA Inc., Wallingford, Connecticut |
BYK-W 980 |
7032 |
06/01/2007 |
April 30, 2008 |
|
Hexion Specialty Chemicals Inc., Houston, Texas |
EPIKURE™ 8537-WY-60 Curing Agent |
7080 |
07/20/2007 |
May 30, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE LIQUID (SERIES 200) |
7101 |
8-1-2007 |
March 14, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE LIQUID (SERIES 300) |
7102 |
8-1-2007 |
March 14, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE LIQUID (SERIES 400) |
7103 |
8-1-2007 |
March 14, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE POWDER (SERIES 200) |
7104 |
8-1-2007 |
January 29, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE POWDER (SERIES 300A) |
7105 |
8-1-2007 |
January 29, 2008 |
|
Chemtrade Logistics Inc., North York, Ontario |
VIRWITE POWDER (SERIES 300B) |
7106 |
8-1-2007 |
January 29, 2008 |
Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on May 21, 2005, listed the subject of the claim bearing Registry Number 6183 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients.
2. The Notice of Filing published in the Canada Gazette, Part I, on July 8, 2005, listed the subject of the claim bearing Registry Number 6238 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of one ingredient.
3. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6246 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
4. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6274 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.
5. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6277 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
6. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6304 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of four ingredients.
7. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6468 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
8. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6476 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the concentration of one ingredient.
9. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6477 and 6478 to be the chemical identity of five ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of six ingredients and the concentration of seven ingredients.
10. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6491 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
11. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6497, 6498 and 6499 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.
12. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6500 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
13. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, made no mention of the subject of the claim bearing Registry Number 6501. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
14. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006 listed the subject of the claim bearing Registry Number 6502 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
15. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subjects of the claims bearing Registry Numbers 6503, 6504 and 6505 to be the chemical identity of three, two and two ingredients respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of four, three and three ingredients, respectively.
16. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subjects of the claims bearing Registry Numbers 6506, 6507 and 6508 to be the chemical identity of two, three and two ingredients, respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of three, five and four ingredients, respectively.
17. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6509 and 6510 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.
18. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6511 through 6514, 6516, 6517 and 6519 through 6524 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of three ingredients.
19. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6515 and 6518 to be the chemical identity of three ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of five ingredients.
20. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6534 to be the chemical name, common name, generic name, trade name or brand name of a controlled product of one ingredient. The subject of the claim on which the screening officer issued the decision is the trade name and information which could be used to identify the supplier of a controlled product. The Notice also incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6534 as CAN1000. The correct product identifier is CAN-1000.
21. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6538 to be the chemical name, common name, generic name, trade name or brand name of a controlled product of four ingredients. The subject of the claim on which the screening officer issued the decision is the trade name and information which could be used to identify the supplier of a controlled product. The Notice also incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6538 as CAN1100. The correct product identifier is CAN-1100.
22. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claims bearing Registry Numbers 6539 and 6540 to be the chemical name, common name, generic name, trade name or brand name of a controlled product of five ingredients. The subject of the claims on which the screening officer issued the decisions is the trade name and information which could be used to identify the supplier of a controlled product. The Notice also incorrectly listed the product identifiers for the controlled product associated with the claims bearing Registry Numbers 6539 and 6540 as RS CLEAN S and RS CLEAN PA, respectively. The correct product identifiers are Res-Clean S and Res-Clean PA, respectively.
23. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6552 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
24. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6554 to be the chemical name, common name, generic name, trade name or brand name of a controlled product and information which could be used to identify the supplier of a controlled product of one ingredient. It also identified the claim as seeking exemption from the disclosure of employer confidential information in respect of a controlled product which would otherwise be required to be disclosed by the provisions of the applicable provincial legislation relating to occupational health and safety.
It has since been established that the subject of the claim is the chemical identity of one ingredient and the claim is seeking exemption from the disclosure of supplier confidential business information in respect of a controlled product; such disclosure would otherwise be required under the provisions of the Hazardous Products Act. The screening officer issued the decision on that basis.
25. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6567 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
26. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6608 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
27. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6611 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
28. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6627 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
29. The Notice of Filing published in the Canada Gazette, Part I, on July 15, 2006, listed the subject of the claim bearing Registry Number 6654 to be the chemical identity of one ingredient and the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients and the concentration of three ingredients.
30. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claim bearing Registry Number 6699 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
31. The Notice of Filing published in the Canada Gazette, Part I, on December 2, 2006, listed the subject of the claims bearing Registry Numbers 6711 and 6766 to be the chemical identity of two ingredients. The subject of the claims on which the screening officer issued the decisions is the chemical identity of one ingredient.
32. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claim bearing Registry Number 6822 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients and the concentration of three ingredients.
33. The Notice of Filing published in the Canada Gazette, Part I, on March 24, 2007, listed the subject of the claims bearing Registry Numbers 6881 and 6882 to be the chemical identity and concentration of one ingredient. The subject of the claims on which the screening officer issued the decisions is the concentration of one ingredient.
34. The Notice of Filing published in the Canada Gazette, Part I, on June 30, 2007, listed the subject of the claim bearing Registry Number 6908 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
35. The Notice of Filing published in the Canada Gazette, Part I, on September 8, 2007, listed the subjects of the claims bearing Registry Numbers 7101, 7102, 7103, 7104, 7105 and 7106 to be the chemical identity and concentration of four, four, two, two, three and three ingredients, respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity and the concentration of two, two, one, one, two and two ingredients, respectively.
There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs or labels.
Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the claims bearing Registry Numbers 6410, 6492, 6493, 6586, 6594, 6724 and 6766 were filed complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.
In the case of the claims bearing Registry Numbers 6231, 6566, 6567, 6568, 6569 and 6570, being claims from employers in the province of Ontario, the screening officer found that the MSDSs relating to these claims and the label relating to the claim bearing Registry Number 6231 did not comply with the applicable disclosure requirements of the Occupational Health and Safety Act of the Province of Ontario.
In the case of the claims bearing Registry Numbers 6411, 6487, 6534, 6538, 6539 and 6540, being claims from employers in the province of Alberta, the screening officer found that the MSDSs relating to these claims and the labels relating to the claims bearing Registry Numbers 6411, 6534, 6538, 6539 and 6540 did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta.
Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the remaining claims were filed did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.
Registry Number 6082
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Remove the concentration range shown for the confidential hazardous ingredient severely hydrotreated naphthenic petroleum distillates and disclose its actual concentration or an acceptable range value;
2. Disclose an LD50 (oral, rat) value of 1 720 mL/kg and an LD50 (dermal, rabbit) value of 1.00 mL/kg for monoethanolamine;
3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E;
4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;
5. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;
6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water or milk to drink. Add information to the effect that no attempt should be made to give anything by mouth to a person who is rapidly losing consciousness, or is unconscious or convulsing, and that if vomiting occurs naturally, have the casualty lean forward to reduce the risk of aspiration.
Registry Number 6183
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of sodium hydrosulfite in an acceptable manner;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water;
3. Remove the statement indicating that the controlled product is slightly to moderately irritating as opposed to being a corrosive material.
Registry Numbers 6221 to 6223, inclusive
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the Exposure Limit Values ACGIH TLV–TWA = 200 ppm and ACGIH TLV–STEL = 300 ppm for 2-butanone;
2. Add hydrogen chloride to the list of hazardous decomposition products;
3. Registry Number 6221: Disclose the percent concentration of
2-butanone in an acceptable manner;
4. Registry Number 6222: Disclose the presence of two additional hazardous ingredients in the controlled product, together with their CAS registry numbers and percent concentrations;
5. Registry Number 6223:
(a) Disclose the percent concentration of titanium dioxide in an acceptable manner;
(b) Add oxides of nitrogen and sulphur to the list of hazardous decomposition products;
(c) Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).
Registry Number 6224
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of acetone in an acceptable manner;
2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;
3. Add oxides of chlorine to the list of hazardous combustion products.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6225
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentrations of aniline derivative and poly(aromatic glycidyl ether) in an acceptable manner;
2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;
3. Add oxides of chlorine to the list of hazardous combustion products;
4. Disclose that exposure to diglycidyl ether of bisphenol A has caused respiratory sensitization in workers;
5. Disclose that the monocyclic organic compound has been shown to cause dermal sensitization in laboratory animals.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6226
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number, percent concentration, ACGIH Exposure Limit Value and the fact that it has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);
2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian and bacterial cells in vitro;
3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6227
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of methylene chloride in an acceptable manner;
2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;
3. Disclose the Exposure Limit Value AIHA WEEL–TWA = 1 mg/m3 for the acrylic monomer;
4. Add oxides of chlorine to the list of hazardous combustion products;
5. Disclose an LC50 value for one of the confidential hazardous ingredients in an acceptable manner;
6. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian and bacterial cells in vitro;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6228
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration;
2. Disclose the presence of a second additional hazardous ingredient in the controlled product, together with its CAS registry number, percent concentration and the fact that it has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);
3. Add oxides of sulphur and chlorine to the list of hazardous combustion products;
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6230
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6231
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;
In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose the HMIRC registry number and the date of the decision granting the exemption;
2. In relation to the first aid information shown on the label for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;
3. In relation to the first aid information shown on the label for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;
4. In relation to the first aid information shown on the label for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
Registry Number 6235
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;
4. Disclose an LD50 (dermal, rabbit) value of 1.58 mL/kg for
2-butoxyethyl acetate;
5. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6238
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
Registry Number 6246
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
2. Disclose the presence of oleic acid in the controlled product, its CAS Registry Number 112-80-1 and its percent concentration.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Numbers 6249 to 6251, inclusive
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Registry Number 6250: In section 11, correctly disclose that the value of 1 862 mg/kg (oral mouse) is an LD50 rather than an LDLo value;
2. Registry Number 6251:
(a) In relation to the first aid information shown on the MSDS for ingestion, clarify that fluid is to be administered only under medical supervision;
(b) In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to “fifteen minutes” and replace it with a time of “from fifteen to thirty minutes.”
Registry Number 6261
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Delete the statement which indicates that the ingredient zinc alkyldithiophosphate is a WHMIS confidential ingredient;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 15 minutes;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;
4. Add oxides of nitrogen to the list of hazardous thermal decomposition products;
5. Remove the statement that the controlled product does not meet the criteria for a classification of D2B as an eye irritant.
Registry Numbers 6274 and 6277
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement indicating one should give large quantities of water to drink;
3. Disclose oxides of carbon, phosphorus and nitrogen as hazardous combustion products;
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;
5. Registry Number 6274:
(a) Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity;
(b) In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;
(c) In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
(d) Disclose a lower LD50 (oral, rat) value of 2.46 mL/kg and a lower LD50 (dermal, rabbit) value of 2.38 mL/kg for 2-ethylhexanol;
(e) Disclose a lower LD50 (dermal, rabbit) value of 400 mg/kg and an LC50 (4 hours, rat) value of 450 ppm for one of the confidential hazardous ingredients.
Registry Number 6283
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 15 minutes.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6287
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of sulphur to the list of hazardous combustion products;
2. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse central nervous system (CNS) effects;
3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.
Registry Numbers 6290 and 6292
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add inhalation and ingestion as routes of entry;
2. Disclose an LD50 (oral, rat) value of 2.46 mL/kg for 2-ethylhexanol;
3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
4. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the thymus, spleen and the immune system in laboratory animals;
5. Disclose that acute ingestion of ingredients in the controlled product has been shown to cause adverse CNS effects in laboratory animals;
6. Disclose that ingestion of an ingredient in the controlled product has been shown to cause irritation to the gastrointestinal tract in laboratory animals;
7. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the prostate and the immune system of laboratory animals;
8. Registry Number 6290: Disclose an LD50 value for the confidential hazardous ingredient in an acceptable manner;
9. Registry Number 6292:
(a) Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;
(b) Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha petroleum, heavy aromatic;
(c) Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;
(d) Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals.
Registry Number 6293
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of sulphur to the list of hazardous combustion products;
2. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects;
3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals.
Registry Numbers 6294 and 6295
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add inhalation and ingestion as routes of entry;
2. Correct the impression that naphthalene and 1,2,4trimethylbenzene are regulated components of the controlled product;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
4. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha petroleum, heavy aromatic;
5. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals;
6. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride;
7. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause CNS effects in laboratory animals;
8. Remove the statement that the controlled product is practically non-toxic in contact with the skin;
9. Registry Number 6294:
(a) Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
(b) Disclose an LD50 value for the confidential hazardous ingredient in an acceptable manner;
(c) Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals;
(d) Disclose that acute inhalation of an ingredient in the controlled product has caused central nervous system effects and irritation to the respiratory tract in laboratory animals;
(e) Disclose that chronic ingestion of ingredients in the controlled product has been shown to cause CNS effects, gastrointestinal disturbances and adverse effects on the blood, kidney and liver of laboratory animals;
(f) Disclose that an ingredient in the controlled product has been shown to be a moderate skin irritant in rabbits;
10. Registry Number 6295: Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner.
Registry Numbers 6296 and 6297
The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;
2. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;
3. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha petroleum, heavy aromatic;
4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
5. Registry Number 6297:
(a) Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
(b) Disclose an LD50 value for a second confidential hazardous ingredient in an acceptable manner;
(c) Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals;
(d) Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous, gastrointestinal and respiratory systems.
Registry Numbers 6298 and 6299
The claimant has been ordered to amend certain aspects of the format and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
2. Disclose LD50 values for one of the confidential hazardous ingredients in an acceptable manner;
3. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous, gastrointestinal and respiratory systems;
4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
5. Registry Number 6298: In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
6. Registry Number 6299: Disclose an LD50 value for a second confidential hazardous ingredient in an acceptable manner.
Registry Numbers 6300 and 6302
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
3. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
4. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous and respiratory systems in laboratory animals;
5. Registry Number 6302:
(a) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause skin irritation and CNS effects in laboratory animals;
(b) If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2B and B3.
Registry Number 6303
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose an LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
2. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the gastrointestinal system and cause growth retardation in laboratory animals;
3. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects and gastrointestinal tract disturbances;
4. Disclose that acute inhalation of high doses of an ingredient in the controlled product has been shown to cause CNS depression and adverse lung effects in laboratory animals;
5. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride;
6. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride and chloroform.
Registry Number 6304
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the impression that naphthalene and
1,2,4-trimethylbenzene are regulated components of the controlled product;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;
3. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause harmful effects on the central nervous and respiratory systems in laboratory animals;
4. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause skin irritation and CNS effects in laboratory animals.
Registry Number 6305
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correct the impression that naphthalene is a regulated component of the controlled product;
2. Add inhalation and ingestion as routes of entry;
3. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum), heavy aromatic;
4. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
5. Disclose that ingestion of an ingredient in the controlled product potentiates the hepatotoxicity of carbon tetrachloride.
Registry Numbers 6317 and 6318
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of hydrotreated light naphthenic distillates in the controlled product, their CAS Registry Number 64742-53-6 and their percent concentration;
2. Disclose an LC50 (4 hours, rat, aerosol) value of 2 180 mg/m3 for hydrotreated light naphthenic distillates;
3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.
Registry Number 6411
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose the HMIRC registry number.
Registry Number 6412
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that an ingredient in the controlled product has been shown to be corrosive to the skin of laboratory animals;
2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;
3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.
Registry Number 6418
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the lower LD50 (dermal, rabbit) value of 3.44 mL/kg for
2-phenoxyethanol.
Registry Number 6425
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with large amounts of water for at least 30 minutes;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with large amounts of water for at least 30 minutes;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement indicating one should give large quantities of water to drink. Add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.
Registry Number 6437
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of certain of the hazardous ingredients in an acceptable manner;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 60 minutes;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose that flushing should continue for at least 60 minutes and that medical attention should be obtained immediately.
Registry Number 6438
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current reference to at least fifteen minutes and replace it with a time of “at least thirty minutes.”
Registry Number 6468
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
3. Disclose that metal containers should be grounded when transferring large quantities of the controlled product.
Registry Number 6469
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the percent concentrations of epoxy/phenolic resin and phenolic epoxy resin in an acceptable manner;
2. Add oxides of nitrogen to the list of hazardous decomposition products.
Registry Number 6470
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;
2. Correct the impression that tetrabromobisphenol A is a regulated component of the controlled product;
3. Add hydrogen chloride to the list of hazardous decomposition products;
4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
Registry Number 6471
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;
2. Add hydrogen chloride to the list of hazardous decomposition products.
Registry Number 6476
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an LC50 (4 hours, female rat) value of 450 ppm for
2-butoxyethanol;
2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
3. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Numbers 6476 and 6477
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product;
2. Disclose the Exposure Limit Value ACGIH TLV–TWA = 0.2 ppm for the confidential hazardous ingredient acid 2;
3. Disclose a lower oral LD50 value for one of the confidential hazardous ingredients in an acceptable manner;
4. Disclose a lower bound to the dermal LD50 value for another of the confidential hazardous ingredients;
5. Disclose a lower bound to the oral LD50 value for a third confidential hazardous ingredient;
6. In relation to the first aid information shown on the MSDS for skin contact, disclose that immediate medical attention should be sought in all cases, and that flushing should continue for at least 30 minutes;
7. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;
8. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
9. Add oxides of sulphur to the list of hazardous combustion products;
10. Correctly disclose the information pertaining to hazardous decomposition products and incompatible substances relative to the pertinent subheadings;
11. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals.
Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.
Registry Number 6487
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
2. Correct the impression that naphthalene and oxyalkylated alcohol (1) are regulated components of the controlled product;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
5. Remove the ACGIH TLV designation from the disclosed exposure limit value for nuisance dusts.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6488
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.
Registry Number 6491
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Correct the impression that “paraffin waxes” are a regulated component of the controlled product.
Registry Number 6495
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause CNS effects in laboratory animals;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 30 minutes;
3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 30 minutes;
4. Disclose an LD50 (dermal, rabbit) value of 3 400 mg/kg for isobutanol.
Registry Numbers 6497 to 6499, inclusive
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
7. Registry Numbers 6497 and 6499:
(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
8. Registry Numbers 6498 and 6499: Disclose that an ingredient in the controlled product is considered to be a somatic cell mutagen based on positive results in an in vivo screening test.
Registry Number 6500
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
4. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
5. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
6. Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
7. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
8. Disclose that an ingredient in the controlled product is considered to be a somatic cell mutagen based on positive results in an in vivo screening test;
9. Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals.
Registry Numbers 6501 and 6502
The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
5. Disclose an LD50 (oral, rat) value of 1 694 mg/kg and an LD50 (dermal, rabbit) value of 6 929 mg/kg for the confidential hazardous ingredient photoinitiator;
6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene.
Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.
Registry Numbers 6503 to 6505, inclusive
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
5. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
6. Registry Number 6503:
(a) Add oxides of nitrogen to the list of hazardous combustion products;
(b) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(c) Disclose an LD50 (oral, rat) value of 1 694 mg/kg and an LD50 (dermal, rabbit) value of 6 929 mg/kg for the confidential hazardous ingredient photoinitiator;
(d) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
(e) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
7. Registry Numbers 6404 and 6405:
(a) Correct the implication that ethylbenzene is an ingredient of the controlled product;
(b) Add oxides of nitrogen and sulphur to the list of hazardous combustion products.
Registry Numbers 6506 to 6508, inclusive
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
3. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
4. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
5. Registry Number 6506: Correctly identify the ACGIH TLV–TWA and TLV–STEL values for the ingredient xylene;
6. Registry Number 6507:
(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
7. Registry Number 6508:
(a) Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
(b) Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
(c) Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals.
Registry Numbers 6509 and 6510
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
7. Registry Number 6509: Correct the implication that ethylbenzene is an ingredient of the controlled product;
8. Registry Number 6510:
(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects.
Registry Numbers 6511 to 6515, inclusive
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
5. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
6. Registry Number 6512:
(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
7. Registry Number 6513: Remove the concentration range shown for the pair of confidential hazardous ingredients disclosed under the term resin and disclose their actual concentrations or acceptable range values;
8. Registry Number 6514: Add oxides of nitrogen to the list of hazardous combustion products;
9. Registry Numbers 6511, 6512, 6513 and 6515: Add oxides of nitrogen and sulphur to the list of hazardous combustion products.
Registry Numbers 6516 and 6517
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
3. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
4. Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
5. Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
6. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
7. Registry Number 6516:
(a) Remove the inference that the ingredient known as azo nickel complex pigment was a part of the claim for exemption;
(b) Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
8. Registry Number 6517:
(a) Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
(b) Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
(c) Add oxides of nitrogen to the list of hazardous combustion products;
(d) Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene.
Registry Numbers 6518 to 6521, inclusive
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
5. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
6. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
7. Registry Numbers 6520 and 6521:
(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects;
8. Registry Numbers 6518, 6519 and 6520: Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals.
Registry Numbers 6522 to 6524, inclusive
The claimant has been ordered to amend certain aspects of the format, content and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of xylene in the controlled product, its CAS Registry Number 1330-20-7 and its percent concentration;
2. Correct the implication that ethylbenzene is an ingredient of the controlled product;
3. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;
4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
6. Add oxides of nitrogen and sulphur to the list of hazardous combustion products;
7. Disclose the Exposure Limit Values ACGIH TLV–TWA = 100 ppm and ACGIH TLV–STEL = 150 ppm for xylene;
8. Registry number 6524:
(a) Disclose an LD50 (oral, rat) value of 1.26 g/kg and an LD50 (dermal, rabbit) value of 2.03 mL/kg for 2-phenoxyethanol;
(b) Disclose that both oral and dermal exposure to an ingredient in the controlled product have been shown to cause adverse effects on red blood cells in laboratory animals;
(c) Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause adverse CNS effects.
Registry Number 6534
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the supplier name, mailing address and emergency telephone number of the supplier of the controlled product;
2. If the WHMIS pictograms are displayed on the MSDS, disclose the appropriate hazard symbol for a class D1 substance.
In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose the HMIRC registry number and information relating to the progress of the claim.
Registry Number 6538
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the supplier name, mailing address and emergency telephone number of the supplier of the controlled product;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;
In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose the HMIRC registry number and information relating to the progress of the claim.
Registry Number 6539
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Remove the inference that isopropanol and methyl alcohol were part of the claim for exemption;
2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;
3. If the WHMIS pictograms are displayed on the MSDS, disclose the appropriate hazard symbol for a class D1 substance.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose the HMIRC registry number and information relating to the progress of the claim.
Registry Number 6540
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the supplier name, mailing address and emergency telephone number of the supplier of the controlled product;
2. If the WHMIS classifications are stated on the MSDS, amend the disclosure to state that the controlled product is in subdivision D1B rather than D1A;
3. If the WHMIS pictograms are displayed on the MSDS, disclose the appropriate hazard symbol for a class D1 substance.
In the opinion of the screening officer, certain information should also have been shown on the label. The claimant has been ordered to amend the label as indicated below.
1. Disclose the HMIRC registry number and information relating to the progress of the claim.
Registry Number 6542
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Delete the statement which indicates that the ingredient zinc alkyldithiophosphate is a WHMIS confidential ingredient;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6547
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add hydrogen chloride and oxides of sulfur to the list of hazardous decomposition products.
Registry Number 6552
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of the hazardous ingredients in an acceptable manner;
2. Delete the statement which indicates that the ingredient proprietary component is a WHMIS confidential ingredient;
3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;
4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
5. Disclose oxides of carbon as hazardous combustion products;
6. Disclose correct information concerning the potential for polymerization of the controlled product;
7. Disclose an LD50 (oral, rat) value of 3 089 mg/kg, an LD50 (dermal, rabbit) value of 870 mg/kg and an LC50 (4 hours, vapour, mouse) value of 2 024 ppm for 2-propoxyethanol.
Registry Number 6554
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Numbers 6566 and 6567
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;
2. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity;
3. Registry Number 6566: Disclose an LC50 (4 hours, rat) value of 7 093 ppm for methyl methacrylate;
4. Registry Number 6567:
(a) Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
(b) In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 20 minutes;
(c) Disclose oxides of carbon as hazardous combustion products.
Registry Number 6568
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15–30 minutes;
3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with water for 15–30 minutes;
4. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.
Registry Number 6569
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for at least 20 minutes;
3. Disclose oxides of carbon as hazardous combustion products;
4. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.
Registry Number 6570
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause lesions of the nasal cavity and lung damage in laboratory animals;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15–30 minutes;
3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with water for 15–30 minutes.
Registry Numbers 6582 and 6583
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Replace the incorrect CAS No. 7711-50-0 with the correct CAS No. 77111-15-0.
Registry Number 6585
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system depression in laboratory animals;
2. Disclose that absorption of an ingredient in the controlled product has been shown to cause CNS depression in laboratory animals;
3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause anemia and adverse effects on the brain, heart, and male reproductive organs in laboratory animals;
4. Disclose that chronic dermal exposure to an ingredient in the controlled product has been shown to cause anemia and adverse effects on the brain and heart in laboratory animals;
5. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the respiratory system and male reproductive organs of laboratory animals;
6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;
7. In relation to the first aid information for skin and eye contact already disclosed on the MSDS, add a statement to the effect that medical attention be obtained immediately;
8. Disclose oxides of carbon and nitrogen as hazardous combustion products;
9. Disclose the Exposure Limit Value ACGIH TLV–TWA = 2 mg/m3 (skin) for diethanolamine;
10. Disclose an LD50 (oral, female rat) value of 0.62 mL/kg and an LD50 (dermal, male rabbit) value of 7.46 mL/kg for diethanolamine.
Registry Number 6608
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of two additional confidential hazardous ingredients in the controlled product, together with their percent concentrations;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose that flushing should continue for 20 minutes;
3. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6611
The claimant has been ordered to amend certain aspects of the format of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink. Add a statement to the effect that fluid is to be administered only under medical supervision;
2. Add oxides of nitrogen to the list of hazardous decomposition products;
3. Remove the ACGIH TLV designation from the disclosed Exposure Limit Value for particulates (not otherwise classified).
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6627
The claimant has been ordered to amend certain aspects of the format and wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Correctly identify the Exposure Limit Values for the confidential hazardous ingredient carboxylic acid ester;
2. Disclose Exposure Limit Values for another of the confidential hazardous ingredients;
3. Disclose that chronic inhalation of an ingredient in the controlled product has caused diminished vision, gastrointestinal upset and effects on the central nervous system;
4. Correctly identify the LD50 (oral, rat) value of 10 600 mg/kg as belonging to the controlled product rather than “CBI#1”;
5. Disclose an LD50 (dermal, rat) value of 16 466 mg/kg and an LC50 (4 hours, rat) value of 1 175 ppm for the controlled product;
6. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity;
7. Disclose that ingredients in the controlled product have been shown to cause fetotoxic effects in laboratory animals.
Registry Number 6640
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration.
Registry Number 6641
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of acetone in an acceptable manner;
2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration.
Registry Number 6642
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add hydrogen chloride to the list of hazardous decomposition products.
Registry Number 6643
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add hydrogen chloride to the list of hazardous decomposition products.
Registry Number 6644
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add hydrogen chloride and oxides of sulphur to the list of hazardous decomposition products.
Registry Number 6645
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add hydrogen chloride to the list of hazardous decomposition products.
Registry Number 6654
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the ceiling Exposure Limit Value of 100 ppm for the confidential hazardous ingredient alcohol 1;
2. Disclose the lower LD50 (oral, rat) value of 4 000 mg/kg for the confidential hazardous ingredient alcohol 1;
3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver and kidney damage in laboratory animals;
4. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse kidney effects in laboratory animals.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6667
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 20 minutes or until the chemical is removed;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink;
3. Disclose oxides of carbon, sulphur and nitrogen as hazardous combustion products.
Registry Number 6676
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Clarify that the ACGIH TWA Exposure Limit Value of 100 ppm shown on the MSDS for the hazardous ingredient n-amyl acetate is actually a “STEL” value and further disclose the Exposure Limit Value ACGIH TLV–TWA = 50 ppm for the same ingredient;
2. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;
3. Disclose the lower Exposure Limit Value ACGIH TLV–STEL = 150 ppm for xylene;
4. Disclose the Exposure Limit Value ACGIH TLV–STEL = 250 ppm (skin) for methanol and add the skin notation to the ACGIH TLV–TWA value as well;
5. Disclose the Exposure Limit Value AIHA WEEL (TWA, 8 hours) = 50 ppm for propylene glycol monomethyl ether acetate;
6. Correct the implication that ethylbenzene is an ingredient of the controlled product;
7. Disclose that acute dermal exposure to an ingredient in the controlled product has caused skin corrosion and renal failure;
8. Disclose that acute inhalation of ingredients in the controlled product has caused CNS effects;
9. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;
10. Disclose that chronic inhalation of a second ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;
11. Disclose that ingestion of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;
12. Revise the MSDS to show that formaldehyde has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);
13. In relation to the first aid information shown on the MSDS for ingestion, indicate that vomiting should not be induced;
14. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes. Also disclose that contaminated clothing, including contaminated footwear and leather goods, should be removed under running water;
15. Disclose an LD50 (oral, rat) value of 10 060 mg/kg and an LC50 (4 hours, rat) value of 31 600 ppm for ethanol;
16. Disclose an LD50 (oral, rat) value of 2.51 g/kg for n-butyl alcohol;
17. Disclose an LD50 (oral, rat) value of 7 000 mg/kg for n-amyl acetate;
18. Disclose an LD50 (oral, rat) value of 2 900 mg/kg for phenol-formaldehyde resin;
19. Disclose an LD50 (oral, rat) value of 13.0 mL/kg and an LD50 (dermal, rabbit) value of 15 800 mg/kg for methanol;
20. Disclose an LD50 (oral, rat) value of 530 mg/kg for phenol;
21. Disclose an LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;
22. Disclose an LD50 (dermal, rabbit) value of 14.1 mL/kg and an LC50 (4 hours, female rat) value of 5 100 ppm for toluene;
23. Disclose that an ingredient in the controlled product is considered to be a germ cell mutagen based on positive results in in vivo screening tests and that it has been shown to cause mutagenic effects in human cells, in vitro;
24. Disclose that another ingredient in the controlled product has shown positive test results in in vitro screening tests for mutagenicity;
25. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.
Registry Number 6678
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Clarify that the ACGIH TWA Exposure Limit Value of 100 ppm shown on the MSDS for the hazardous ingredient n-amyl acetate is actually a “STEL” value and further disclose the Exposure Limit Value ACGIH TLV–TWA = 50 ppm for the same ingredient;
2. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;
3. Disclose the lower Exposure Limit Value ACGIH TLV–STEL = 150 ppm for xylene;
4. Disclose the Exposure Limit Value ACGIH TLV–STEL = 250 ppm (skin) for methanol and add the skin notation to the ACGIH TLV–TWA value as well;
5. Disclose the Exposure Limit Value AIHA WEEL (TWA, 8 hours) = 50 ppm for propylene glycol monomethyl ether acetate;
6. Disclose the Exposure Limit Value ACGIH TLV–STEL = 250 ppm for n-propyl acetate;
7. Disclose the Exposure Limit Value ACGIH TLV–STEL = 200 ppm for n-butyl acetate;
8. Correct the implication that ethylbenzene is an ingredient of the controlled product;
9. Disclose that acute dermal exposure to an ingredient in the controlled product has caused skin corrosion and renal failure;
10. Disclose that acute inhalation of ingredients in the controlled product has caused CNS effects;
11. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;
12. Disclose that chronic inhalation of a second ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;
13. In relation to the first aid information shown on the MSDS for ingestion, indicate that vomiting should not be induced;
14. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes. Also disclose that contaminated clothing, including contaminated footwear and leather goods, should be removed under running water;
15. Disclose an LD50 (oral, rat) value of 9.8 mL/kg for n-propyl acetate;
16. Disclose an LD50 (oral, rat) value of 10 060 mg/kg and an LC50 (4 hours, rat) value of 31 600 ppm for ethanol;
17. Disclose an LD50 (oral, rat) value of 2.51 g/kg for n-butyl alcohol;
18. Disclose an LD50 (oral, rat) value of 7 000 mg/kg for n-amyl acetate;
19. Disclose an LD50 (oral, rat) value of 2 900 mg/kg for phenol-formaldehyde resin;
20. Disclose an LD50 (oral, rat) value of 13.0 mL/kg and an LD50 (dermal, rabbit) value of 15 800 mg/kg for methanol;
21. Disclose an LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;
22. Disclose an LD50 (dermal, rabbit) value of 14.1 mL/kg and an LC50 (4 hours, female rat) value of 5 100 ppm for toluene;
23. Disclose an LC50 (4 hours, aerosol, rat) value of 160 ppm for n-butyl acetate;
24. Disclose that an ingredient in the controlled product is considered to be a germ cell mutagen based on positive results in in vivo screening tests and that it has been shown to cause mutagenic effects in human cells, in vitro;
25. Disclose that a second ingredient in the controlled product has shown positive results in in vivo screening tests for mutagenicity;
26. Disclose that an ingredient in the controlled product is considered to be a fetotoxin and that another ingredient has been shown to be a fetotoxin (by inhalation), in tests on laboratory animals;
27. Revise the MSDS to show that formaldehyde has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);
28. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.
Registry Number 6680
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;
2. Correct the implication that ethylbenzene is an ingredient of the controlled product;
3. Disclose that chronic exposure to xylene vapours has caused skin sensitization in a worker;
4. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects and gastrointestinal tract disturbances;
5. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;
6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals in the absence of maternal toxic effects and that another ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;
7. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed for at least 20 minutes and that medical attention should be obtained immediately;
8. Disclose an LD50 (oral, rat) value of 2.51 g/kg for n-butyl alcohol;
9. Disclose an LD50 (oral, rat) value of 9.8 mL/kg for n-propyl acetate;
10. Disclose an LD50 (oral, rat) value of 3 523 mg/kg and an LC50 (4 hours, rat) value of 6 350 ppm for xylene;
11. Disclose an LD50 (dermal, rabbit) value of 12 800 mg/kg and an LC50 (8 hours, rat) value of 12 000 ppm for isopropanol;
12. Disclose an LD50 (dermal, rabbit) value of 14.1 mL/kg for toluene;
13. Disclose that acetylsalicylic acid synergistically enhances the hearing loss caused by inhalation exposure to toluene in laboratory animals.
Registry Number 6682
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Add oxides of sulfur to the list of hazardous decomposition or combustion products;
2. Disclose the LD50 (oral, rat) value of 1 410 mg/kg for the confidential hazardous ingredient proprietary aromatic acid.
Registry Number 6683
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an LD50 (oral, rat) value of 1 020 mg/kg, an LD50 (dermal, rabbit) value of 560 mg/kg and an LC50 (4 hours, aerosol, rat) value of 3 070 mg/m3 for N-vinyl-2-pyrollidone.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Numbers 6685 and 6686
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Registry Number 6689
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of the hazardous ingredients in an acceptable manner;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 30 minutes;
3. Disclose oxides of carbon as hazardous combustion products;
4. Disclose the Exposure Limit Value AIHA WEEL = 10 ppm for benzyl alcohol;
5. Disclose correct information concerning the potential for polymerization of the controlled product;
6. Disclose an LD50 (oral, rat) value of 1 230 mg/kg and an LD50 (dermal, rabbit) value of 2 000 mg/kg for benzyl alcohol;
7. Disclose an LD50 (oral, rat) value of 1 030 mg/kg for isophoronediamine;
8. Disclose that an ingredient in the controlled product has been shown to be corrosive to the eyes of laboratory animals;
9. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells in vitro.
Registry Number 6699
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Delete the statement which indicates that the ingredient proprietary component is a WHMIS confidential ingredient;
2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
4. Disclose oxides of carbon as hazardous combustion products;
5. Disclose an LD50 (oral, rat) value of 3 089 mg/kg, an LD50 (dermal, rabbit) value of 870 mg/kg and an LC50 (4 hours, vapour, mouse) value of 2 024 ppm for 2-propoxyethanol.
Registry Number 6700
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6711
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum) heavy arom;
2. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels.
Registry Numbers 6712 and 6713
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that an ingredient in the controlled product has been shown to cause adverse reproductive effects in laboratory animals;
2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1A and D2A.
Registry Number 6714
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Registry Number 6719
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 30 minutes;
2. Disclose oxides of carbon as hazardous combustion products;
3. Disclose correct information concerning the potential for polymerization of the controlled product.
Registry Number 6725
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.
Registry Number 6726
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;
2. Remove the inference that the ingredient known as alkylamine was a part of the claim for exemption;
3. Disclose LC50 values for one of the confidential hazardous ingredients in an acceptable manner;
4. Disclose that ingestion of an ingredient in the controlled product has caused methemoglobinemia;
5. Disclose that subchronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on sperm production in laboratory animals;
6. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6727
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentrations of N,N-diethyl-p-phenylene-diamine sulfate and organic acid in an acceptable manner;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give diluted milk of magnesia to drink;
3. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink.
Registry Number 6732
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Registry Number 6733
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that acute oral exposure to an ingredient in the controlled product has caused temporary visual disturbances and adverse heart effects in humans and has also been shown to cause bladder and immunological effects in laboratory animals;
2. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss;
3. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;
4. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.
Registry Number 6734
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the lower LD50 (oral, rat) value of 3 000 mg/kg for
o-xylene;
2. Disclose an LD50 (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum) heavy arom;
3. Disclose that ingestion of an ingredient in the controlled product has caused CNS effects.
Registry Numbers 6744 and 6745
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Registry Number 6816
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacterial cells in vitro;
2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give large amounts of water to drink;
3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;
4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
5. Disclose oxides of carbon as hazardous combustion products;
6. Disclose an LD50 (dermal, rabbit) value of 400 mg/kg and an LC50 (4 hours, rat) value of 450 ppm for ethylene glycol monobutyl ether;
7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.
Registry Number 6819
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose an LD50 (oral, rat) value of 1 022 mg/kg, an LD50 (dermal, rabbit) value of 560 mg/kg and an LC50 (4 hours, aerosol, rat) value of 3 070 mg/m3 for N-vinyl-2-pyrollidone.
Registry Number 6822
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the Province of Alberta 15 minute occupational exposure limit value of 3 mg/m3 for sulphuric acid;
2. Disclose information pertaining to acute lethality via dermal exposure for one of the confidential hazardous ingredients;
3. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause liver damage in laboratory animals;
4. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current time frame and replace it with a time of “at least thirty minutes”;
5. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current time frame and replace it with a time of “at least thirty minutes”;
6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water to drink.
Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.
Registry Number 6881
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose that medical attention should be obtained.
Registry Number 6882
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose that medical attention should be obtained;
2. Indicate that the flash point is 45°C.
Registry Number 6901
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose that an ingredient in the controlled product has caused potentiating effects with chloroform.
Registry Number 6908
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of certain of the hazardous ingredients in an acceptable manner;
2. Remove the concentration ranges shown for the ingredients poly(aromatic glycidyl ether) and acetone and disclose their actual concentrations or acceptable range values;
3. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;
4. Add oxides of sulphur and chlorine to the list of hazardous combustion products.
Registry Number 6912
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of certain of the hazardous ingredients in an acceptable manner;
2. Disclose the presence of titanium dioxide in the controlled product, its CAS Registry Number 13463-67-7 and its percent concentration;
3. Disclose that an ingredient in the controlled product has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC);
4. Disclose the Exposure Limit Value ACGIH TLV–TWA = 10 mg/m3 for titanium dioxide;
5. Add oxides of chlorine to the list of hazardous combustion products.
Registry Number 6914
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Add oxides of chlorine to the list of hazardous combustion products.
Registry Number 6923
The claimant has been ordered to amend certain aspects of the content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Delete the statement which indicates that the ingredient zinc alkyldithiophosphate is a WHMIS confidential ingredient;
2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed with water for at least 15 minutes;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 15 minutes;
4. Add oxides of nitrogen to the list of hazardous thermal decomposition products;
5. Remove the statement that the controlled product does not meet the criteria for a classification of D2B as an eye irritant.
Registry Number 6949
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. Disclose a lower LD50 (oral, rat) value of 272 mg/kg and a lower LC50 (4 hours, rat, vapour) value of 890 ppm for the confidential hazardous ingredient alkyl amine.
Registry Numbers 7031 and 7032
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes.
Registry Number 7080
The claimant has been ordered to amend certain aspects of the wording of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;
3. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to “ten minutes” and replace it with a time of “at least fifteen minutes”;
4. Add carbon dioxide to the list of hazardous combustion products.
Registry Numbers 7101 to 7103, inclusive
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.
1. Disclose the percent concentration of sodium hydrosulfite in an acceptable manner;
2. Remove the statements implying that the controlled product is corrosive;
3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water.
Registry Numbers 7104 to 7106, inclusive
The claimant has been ordered to amend certain aspects of the format and content of the MSDS.
In the opinion of the screening officer, certain information should have been shown on the MSDS.
Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 6231, 6410, 6411, 6487, 6492, 6493, 6534, 6538, 6539, 6540, 6566, 6567, 6568, 6569, 6570, 6586, 6594, 6724 and 6766, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.
In the cases of the claims bearing Registry Numbers 6231, 6566, 6567, 6568, 6569 and 6570, the screening officer has directed the claimants to comply with the provisions of the Occupational Health and Safety Act of the Province of Ontario, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended MSDS and, in the case of the claim bearing Registry Number 6231, the amended label to the screening officer within the respective time period specified in the foregoing paragraph.
In the cases of the claims bearing Registry Numbers 6411, 6487, 6534, 6538, 6539 and 6540, the screening officer has directed the claimants to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended MSDS and, in the cases of the claims bearing Registry Numbers 6411, 6534, 6538, 6539 and 6540, the amended label to the screening officer, within the respective time period specified in a foregoing paragraph.
Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS.
Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.
Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the acting Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-941-2945.
R. BOARDMAN
Chief Screening Officer
[27-1-o]
